Haemolytic Screen
 

Lactate Dehydrogenase

 
 
Bookmark

Overview

  • Lactate dehydrogenase (LDH) is an enzyme present in the cytoplasm of most cells that catalyses the conversion of lactate to pyruvate.
      • Normal Range

      • 120 - 280 U/L

Elevated LDH

  • LDH is elevated in haemolysis, and markedly in intravascular haemolysis.
  • As LDH is present in all tissues, its elevation is a nonspecific marker of cell damage. Elevation of specific LDH isoenzymes may point toward a specific pathology, as below.
    • Causes of Elevated Lactate Dehydrogenase

    • Factitious (haemolysed sample)
    • Heart - myocardial infarction, heart failure
    • Brain - ischaemic stroke, traumatic brain injury
    • Kidneys - nephritis, nephrotic syndrome, acute tubular necrosis, infarction
    • Anaemia - haemolytic or megaloblastic
    • Malignancy (especially haematological)
    • Lungs - pulmonary embolism, infarction, obstructive disease, interstitial lung disease, pneumonia
    • Spleen - infarction
    • Pancreas - pancreatitis
    • Liver - hepatitis, infarction, cirrhosis, malignancy, trauma
    • Skeletal muscle - strenuous exercise, rhabdomyolysis, myositis
    • Shock
    • Trauma
    • Hypoxia

    LDH Isoenzyme Abnormalities

    • There are five LDH isoenzymes composed of two H (heart) and M (muscle) subunits. The isoenzymes are classified depending on their migration on electrophoresis.
    • The isoenzyme electrophoresis pattern is relatively non-specific, though specific patterns of isoenzyme elevation are classically (yet loosely) associated with certain diseases.
      • Interpretation

      • Elevated LDH1 and LDH2 - myocardial infarction, brain injury, renal pathology, haemolytic or megaloblastic anaemias
      • LDH1 > LDH2 (‘flipped’ LDH) - myocardial infarction
      • Elevated LDH2 and LDH3 - acute leukaemia
      • Elevated LDH3 and LDH4 - splenic or lung pathology
      • Elevated LDH5 - liver or skeletal muscular pathology
    Last updated on January 28th, 2018
     
    ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
    Want more info like this?
    • Your electronic clinical medicine handbook
    • Guides to help pass your exams
    • Tools every medical student needs
    • Quick diagrams to have the answers, fast
    • Quizzes to test your knowledge
    Explore
       
     
     

    Read More...

     Bain BJ. Diagnosis from the blood smear. New England Journal of Medicine. 2005 Aug 4;353(5):498-507. Barcellini W, Fattizzo B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Disease markers. 2015 Dec 27;2015. Choi JW, Pai SH. Change in erythropoiesis with gestational age during pregnancy. Annals of hematology. 2001 Feb 16;80(1):26-31. Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. European Respiratory Journal. 1996 Aug 1;9(8):1736-42. Gorst DW, Rawlinson VI, Merry AH, Stratton F. Positive direct antiglobulin test in normal individuals. Vox sanguinis. 1980 Feb 1;38(2):99-105. Lurie S, Mamet Y. Red blood cell survival and kinetics during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2000 Dec 31;93(2):185-92. Maekawa M. Lactate dehydrogenase isoenzymes. Journal of Chromatography B: Biomedical Sciences and Applications. 1988 Jul 29;429:373-98. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. Jama. 1980 May 16;243(19):1909-11. Papadopoulos NM. Clinical applications of lactate dehydrogenase isoenzymes. Annals of Clinical & Laboratory Science. 1977 Nov 1;7(6):506-10. Parker V, Tormey CA. The Direct Antiglobulin Test: Indications, Interpretation, and Pitfalls. Archives of Pathology & Laboratory Medicine. 2017 Feb;141(2):305-10. Shih AW, McFarlane A, Verhovsek M. Haptoglobin testing in hemolysis: measurement and interpretation. American journal of hematology. 2014 Apr 1;89(4):443-7.
    Tabbara IA. Hemolytic anemias: diagnosis and management. Medical Clinics of North America. 1992 May 1;76(3):649-68.
     Ucar K. Clinical presentation and management of hemolytic anemias. Oncology. 2002 Sep 16;16(9; SUPP/10):163-70. Zantek ND, Koepsell SA, Tharp DR, Cohn CS. The direct antiglobulin test: a critical step in the evaluation of hemolysis. American journal of hematology. 2012 Jul 1;87(7):707-9.
    Feedback